Drug intelligence / Profile preview

Gene-HBvax

Development stage
Unknown
Lead developer
Vabiotech
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Gene-HBvax is a recombinant subunit vaccine developed and manufactured by Vabiotech (Company of Vaccine and Biological Production No.1) in Vietnam for the prevention of Hepatitis B virus (HBV) infection. The vaccine consists of highly purified Hepatitis B surface antigen (HBsAg) produced through recombinant DNA technology in the yeast strain *Hansenula polymorpha*. Upon administration, the HBsAg protein induces the production of specific humoral antibodies (anti-HBs), providing active immunity against all known subtypes of HBV. The formulation is adsorbed on aluminum hydroxide as an adjuvant to enhance the immune response and is administered via intramuscular injection. Gene-HBvax is a cornerstone of Vietnam's National Expanded Program on Immunization (EPI), used for both neonatal prophylaxis and adult immunization.

Brand names
Gene-HBvax
Other names
Recombinant Hepatitis B VaccineVabiotech Hepatitis B Vaccinehepatitis b vaccine (recombinant)
02

Targets

Hepatitis B surface antigen-specific T-cell receptor

Beyond the preview

Go deeper on Gene-HBvax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene-HBvax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call